Day: April 20, 2020

HelloFresh and Lokai Making a Difference Through Carbon OffsetsTerrapass Matching Customer Purchases in Recognition of 50 Years of Earth DayHOUSTON, April 20, 2020 (GLOBE NEWSWIRE) — April 22nd marks 50 years of Earth Day, and to coincide with the milestone, terrapass is excited to announce two new collaborations to its growing list of eco-conscious partners – HelloFresh and Lokai. In selecting terrapass, both companies build on their social and environmental initiatives with carbon offsets to counter their operations-related emissions, and support investment in projects that reduce greenhouse gases in the atmosphere.HelloFresh, the leader in delivering delicious ingredients and easy-to-follow recipes to households worldwide, is committed to sustainable business practices and helping home cooks become more eco-conscious. To add to...

BETHESDA, Md., April 20, 2020 (GLOBE NEWSWIRE) — Arconic Technology Center (ATCATC) and AllSurplus, the newest marketplace of Liquidity Services (NASDAQ: LQDT), have partnered to sell equipment and other assets as ATC consolidates its 2,300-acre campus in New Kensington, PA founded in 1965 for light metals research. ATC is consolidating the operations for its light metals development including aluminum castings, forgings, components and extrusions for the automotive and aerospace industries. All assets are currently available for bidding through a private treaty sale on www.AllSurplus.com and assets will continue to be added throughout the year.“Arconic is a market leader for providing metals materials to the aerospace and automotive industries and this is a rare opportunity for buyers to access the equipment used at their research...

Over 20 percent of Canadians with allergies are impacted by tree polleniWith this approval, ALK now provides four SLIT-tablet options in Canada, treating some of the most prevalent allergiesMISSISSAUGA, Ontario, Apr. 20, 2020 – ALK, a global, research-driven pharmaceutical company that focuses on the prevention, diagnosis and treatment of allergies, today announced that Health Canada has approved once-daily ITULATEKTM (standardised allergen extract, white birch (betula verrucosa) sublingual tablet) for the treatment of tree pollen allergy.ITULATEKTM, the fourth once-daily sublingual allergy immunotherapy (SLIT) tablet available in Canada from ALK, is indicated as an allergy immunotherapy for the treatment of moderate to severe seasonal allergic rhinitis, with or without conjunctivitis, induced by pollen from birch, alder, and/or hazel...

Completion of capital reduction in Demant A/SAs stated in company announcement no. 2020-04, it was decided at Demant A/S’ ordinary general meeting on 10 March 2020 to reduce the company’s share capital by nominally DKK 919,173.40 divided into 4,595,867 shares of DKK 0.20, corresponding to the company’s holding of treasury shares at 4 February 2020 with the deduction of shares to cover Management’s retention programme and the employee share salary arrangement.The capital reduction was published in the electronic information system of the Danish Business Authority on 12 March 2020. The advertisement period expired without any objections being raised. Consequently, we have notified the Danish Business Authority of the capital reduction. After the capital reduction, the share capital of Demant A/S amounts to nominally DKK 48,138,233.60.In...

Gennemførelse af kapitalnedsættelse i Demant A/SSom oplyst i selskabsmeddelelse nr. 2020-04 blev det på Demant A/S’ ordinære generalforsamling den 10. marts 2020 besluttet at nedsætte selskabets aktiekapital med nominelt DKK 919.173,40 fordelt på 4.595.867 aktier a DKK 0,20 svarende til selskabets beholdning af egne aktier pr. 4. februar 2020 fraregnet aktier til dækning af ledelsens fastholdelsesprogram og medarbejdernes aktielønsordning.Offentliggørelse af kapitalnedsættelsen har fundet sted i Erhvervsstyrelsens it-system den 12. marts 2020. Proklamafristen er udløbet uden indsigelser. Kapitalnedsættelsen er derfor anmeldt endeligt til Erhvervsstyrelsen. Efter kapitalnedsættelsen udgør aktiekapitalen i Demant A/S nominelt DKK 48.138.233,60.I henhold til § 32 i lov om kapitalmarkeder oplyses det hermed, at selskabets samlede aktiekapital...

NEW YORK, NY and SAN DIEGO, CA, April 20, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE – As previously announced, Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga”) and Aegea Biotechnologies, Inc. (“Aegea”) have entered into a collaboration agreement to develop COVID-19 (Novel Coronavirus) assays. Aegea has now informed Tauriga Sciences that in addition to the high sensitivity, high specificity COVID-19 assay under development (the “SARS-CoV-2 Test”), Aegea is undertaking to use another of its patented technologies to further expand COVID-19 testing to very simple devices appropriate to point-of-care testing. The patent being applied is core to a follow-on assay designed to use isothermal amplification as covered by US Patent 10,174,352 for METHODS FOR AMPLIFICATION OF NUCLEIC ACIDS ON SOLID SUPPORT. This methodology combines the capture...

RENO, Nev., April 20, 2020 (GLOBE NEWSWIRE) — Maverick Technology Solutions (OTC:MVRK), AKA Rosinbomb industry leading developer and manufacturer of the highly acclaimed ROSINBOMB™ brand of extraction presses and technology, is pleased  to announce that Forbes.com has written an in-depth feature and interview with the company’s President Ryan Mayer and CEO Fred Angelopoulos.Forbes contributor Warren Bobrow asked a series of probing questions about the Rosinbomb brand, products and vision for the company’s future. Mayer and Angelopoulos provide insight into the origins of the company as well as their beliefs and passion to continually innovate the brand and products and push through all barriers on their mission to help the consumer and the commercial developers craft safe, solventless and organic extracts.“We’re very grateful to...

HOUSTON, April 20, 2020 (GLOBE NEWSWIRE) — C-Bond Systems, Inc. (the “Company” or “C-Bond”) (OTC: CBNT), a nanotechnology solutions company, today announced it has licensed its service mark and logo to a leading national insurance company to market its patented C-Bond BRS (ballistic-resistant film system) to the insurer’s property and casualty division customers.Per the terms of the agreement, the insurance group has a non-exclusive, royalty-free, limited license to offer C-Bond BRS to its business customers across all industries. The agreement brings increased visibility of C-Bond BRS to the insurer’s online customers through their web portal.C-Bond BRS is a ballistic-resistant film system that significantly increases glass strength and the performance of window film. C-Bond BRS is validated to pass National Institute of Justice...

LAVAL, Québec, April 20, 2020 (GLOBE NEWSWIRE) — Acasti Pharma Inc. (“Acasti” or the “Company”) (NASDAQ: ACST – TSX-V: ACST), a biopharmaceutical innovator focused on the research, development and commercialization of its prescription drug candidate CaPre® (omega-3 phospholipid) for the treatment of severe hypertriglyceridemia, today announced that it has received a Notice of Allowance for its second composition matter patent to be awarded by the Canadian Intellectual Property Office. This new patent expands the Company’s existing claims to include any composition containing EPA and DHA, where at least 50% of the composition consists of phospholipids.Pierre Lemieux, PhD, Acasti’s Chief Operating Officer and Chief Scientific Officer, commented, “This notice of Allowance for a composition of matter patent builds upon similar...